eKapija | Search news

Number of results: 20

Carlos Puglia, Executive Director of Sales and Marketing at Galenika – Quality, Portfolio Development and Innovations Key Prerequisites for Growth and Competitive Global Presence in the Pharma Industry

Thu 28.09.2023.

Pavle Marjanovic, CEO of Actavis for Serbia and Montenegro – There are no “semi-quality” products in the market

Mon 25.06.2018.

Kare Schultz to head pharmaceutical company Teva

Thu 14.09.2017.

SSCC success story: Predrag Bogavac, Country Head at Novartis Serbia – We intend to further develop and strengthen our presence in Serbia

Thu 23.02.2017.

Cinven offering EUR 3.6 billion for acquisition of Stada?

Tue 14.02.2017.

Germany’s Fresenius SE revises 2016 profit projections up – Earnings in third quarter EUR 399 million

Fri 04.11.2016.

Teva acquires Actavis for USD 33.43 billion and 100 million shares – Modern pharmaceutical drugs and therapies more available to clients in Serbia

Wed 03.08.2016.

Pharmaceutical companies have invested more than EUR 800 million in Serbia

Wed 23.07.2014.

Actavis to boost exports in 2014

Fri 24.01.2014.

Croatia's PharmaS starts producing generic drugs in Zrenjanin

Tue 20.11.2012.